Medicare Enrolled
Dr. Michael Krueger, DO
Cardiovascular Disease · Fresno, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Krueger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Krueger?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Krueger
Dr. Michael Krueger is a cardiovascular disease specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Krueger performed 19,887 Medicare services across 12,693 unique beneficiaries.
Between the years covered by Open Payments, Dr. Krueger received a total of $4,664 from 32 pharmaceutical and/or device companies across 239 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Krueger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$4,664 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,887
Medicare services
Top 1% in CA for cardiovascular disease
12,693
Unique beneficiaries
$135
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~994 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,797 | $63 | $166 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
3,356 | $43 | $237 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,887 | $13 | $67 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,754 | $10 | $60 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 1,464 | $406 | $1,500 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
1,438 | $153 | $941 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
943 | $31 | $147 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
919 | $57 | $292 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
732 | $1,212 | $4,950 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
366 | $47 | $244 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
357 | $108 | $430 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
305 | $19 | $90 |
| Injection, dipyridamole, per 10 mg | 266 | $3 | $24 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
215 | $53 | $95 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
201 | $73 | $179 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
184 | $347 | $1,185 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
172 | $6 | $116 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
166 | $56 | $136 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
144 | $52 | $389 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
118 | $19 | $90 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
118 | $703 | $2,294 |
| Cardiac catheterization | 101 | $163 | $2,950 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
89 | $154 | $711 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
88 | $8 | $168 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
76 | $40 | $207 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
76 | $19 | $186 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
76 | $169 | $847 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $88 | $263 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
60 | $154 | $744 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
50 | $16 | $50 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
48 | $430 | $2,750 |
| Contrast injection for X-ray imaging Administration of a contrast agent into a vein in the arm or leg to enhance visibility during an X-ray imaging procedure. |
30 | $18 | $555 |
| Radiologist review of arm or leg vein image A radiologist reviews an image of a vein in one arm or leg. |
30 | $39 | $180 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
27 | $3,719 | $16,592 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
25 | $42 | $88 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
25 | $16 | $61 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
24 | $85 | $371 |
| Pacemaker/ICD evaluation at implant or replacement Assessment of a single or dual chamber pacing cardioverter-defibrillator and generator during the initial implantation or replacement procedure. |
21 | $124 | $1,046 |
| 30-day continuous ECG with symptom monitoring This procedure involves continuous electrocardiogram monitoring for up to 30 days, including symptom tracking and a professional review and report of the results. |
19 | $145 | $650 |
| Insertion of implantable defibrillator system A surgical procedure to place an implantable cardioverter-defibrillator (ICD) device into the body. The device is connected to the heart to monitor heart rhythm and deliver shocks if dangerous arrhythmias occur. |
18 | $697 | $3,765 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 15 | $219 | $3,900 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $270 | $3,600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.6% high complexity
45.6% medium
43.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,664
Total received (2018-2024)
Avg $666/year across 7 years
Top 42% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
239
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,664 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,080
2023
$939
2022
$756
2021
$591
2020
$382
2019
$458
2018
$459
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$491
Novartis Pharmaceuticals Corporation
$150
Abbott Laboratories
$140
ShockWave Medical, Inc
$128
CARDIVA MEDICAL, INC.
$59
PFIZER INC.
$35
Boston Scientific Corporation
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
iRhythm Technologies, Inc.
$15
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 72.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,106
Abbott Laboratories
$899
Novartis Pharmaceuticals Corporation
$554
AstraZeneca Pharmaceuticals LP
$305
CVRx, Inc.
$224
PFIZER INC.
$207
Gilead Sciences, Inc.
$163
Janssen Pharmaceuticals, Inc
$156
ABIOMED
$139
ShockWave Medical, Inc
$128
Boston Scientific Corporation
$91
Merck Sharp & Dohme LLC
$84
Amarin Pharma Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
CARDIVA MEDICAL, INC.
$59
E.R. Squibb & Sons, L.L.C.
$55
Arbor Pharmaceuticals, Inc.
$53
Aziyo Biologics, Inc.
$37
Kowa Pharmaceuticals America, Inc.
$34
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$34
Astellas Pharma US Inc
$24
Inspire Medical Systems, Inc.
$20
Regeneron Healthcare Solutions, Inc.
$20
Medtronic Vascular, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
InfoBionic, Inc
$16
Novo Nordisk Inc
$16
iRhythm Technologies, Inc.
$15
Daiichi Sankyo Inc.
$15
Tactile Systems Technology Inc
$14
Merck Sharp & Dohme Corporation
$14
Medtronic, Inc.
$12
Top 3 companies account for 54.8% of all-time payments
Associated products mentioned in payments ›
AVEIR · Assurity Pacemaker · BRILINTA · Barostim Neo System · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CONFIRM RX · Confirm Rx · Corlanor · ECM Patch · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FFR LINK · Flexitouch Plus · GALLANT · HeartMate · INJECTAFER · INSPIRE · Impella · JARDIANCE · Kerendia · LEQVIO · LINQ II · Lexiscan · LifeVest · Livalo · MERLIN@HOME · MITRACLIP · MitraClip System · MoMe Kardia · PRALUENT · Pouch · QUADRA ASSURA · Quadra Allure MP RF CRT Pacemkr · Repatha · Reveal LINQ · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · VERQUVO · Vascepa · WATCHMAN FLX · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
41
Per 100K population
4.1
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Krueger is a cardiac imaging specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Krueger experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Krueger performed 3,797 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Krueger receive payments from pharmaceutical companies?
Yes. Dr. Krueger received a total of $4,664 from 32 companies across 239 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Krueger's costs compare to other cardiologists in Fresno?
Dr. Krueger's average Medicare payment per service is $135. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Krueger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Fresno
Browse cardiologists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology